STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife launched a new needle for the collection of human oocytes at ESHRE, the largest congress of the year within IVF. “The needle combines the good properties of our previous needles with a new way of designing the front part and tip, so that the patient will experience less discomfort. We are extremely happy about the positive response and attention that this needle received at the congress,” says Nils Sellbom, Sales Director at Vitrolife.
